Digest Network Come funziona
Network
/
Società
Nu
Non verificato

Nuvation Bio Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaOncologiaSaluteSanità

25 comunicati stampa

Guarda tutti i comunicati
03/11/2025
Biotecnologia
Farmaceutica
Salute
Oncologia
Web e Social Network
Telefonia e Varie
Mercato azionario
Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
Fonte
Nuvation Bio Inc.
Emittente
Business Wire
1.00
0
21/05/2025
Eventi
Industria
Scienza
Igiene alimentare
Biotecnologia
Sanità
Salute
Farmaceutica
Oncologia
Nuvation Bio To Present New Data from Pivotal Clinical Studies of Taletrectinib in Advanced ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2025 Annual Meeting
Fonte
Nuvation Bio Inc.
Emittente
Business Wire
1.00
0
13/05/2025
Eventi
Industria
Oncologia
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Entrectinib at ISPOR 2025
Fonte
Nuvation Bio Inc.
Emittente
Business Wire
1.00
0
12/05/2025
Eventi
Biotecnologia
Sanità
Salute
Farmaceutica
Oncologia
Nuvation Bio to Participate in Upcoming Investor Conferences
Fonte
Nuvation Bio Inc.
Emittente
Business Wire
1.00
0
07/05/2025
Web e Social Network
Telefonia e Varie
Mercato azionario
Oncologia
Salute
Igiene alimentare
Sanità
Farmaceutica
Biotecnologia
Nuvation Bio Reports First Quarter 2025 Financial Results and Provides Business Update
Fonte
Nuvation Bio Inc.
Emittente
Business Wire
1.00
0
01/05/2025
Eventi
Web e Social Network
Oncologia
Salute
Scienza
Farmaceutica
Biotecnologia
Nuvation Bio to Present at The Citizens Life Sciences Conference
Fonte
Nuvation Bio Inc.
Emittente
Business Wire
1.00
0
22/04/2025
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Oncologia
Nuvation Bio to Report Results for First Quarter 2025 and Provide Business Update on May 7, 2025
Fonte
Nuvation Bio Inc.
Emittente
Business Wire
1.00
0
02/04/2025
Eventi
Industria
Web e Social Network
Telefonia e Varie
Scienza
Biotecnologia
Farmaceutica
Oncologia
Sanità
Salute
Nuvation Bio to Present at the Jones Healthcare and Technology Innovation Conference
Fonte
Nuvation Bio Inc.
Emittente
Business Wire
1.00
0
25/03/2025
Industria
Eventi
Scienza
Biotecnologia
Farmaceutica
Oncologia
Salute
Sanità
Nuvation Bio to Present New Nonclinical Data for Taletrectinib at the American Association for Cancer Research Annual Meeting 2025
Fonte
Nuvation Bio Inc.
Emittente
Business Wire
1.00
0
25/03/2025
Eventi
Biotecnologia
Sanità
Salute
Farmaceutica
Oncologia
Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Crizotinib During Mini Oral Presentation at the European Lung Cancer Congress 2025
Fonte
Nuvation Bio Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0